FdaApplication

NDA 022118

Back to search

Identifiers

Properties

PropertyValue
applicant_nameSALIX PHARMACEUTICALS INC
application_typeNDA
approval_date2007-08-10

Products (2)

ProductActive ingredientStrengthDosage form
FENOGLIDEFENOFIBRATE120MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET;ORAL
FENOGLIDEFENOFIBRATE40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET;ORAL

2 products